Assessing economic vulnerability to emerging infectious disease outbreaks: Ebola versus Zika

Similar documents
Zika Operation: IMPACT IN THE AMERICAS. Americas Regional Office

Preventing disease Promoting and protecting health

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

WHO: Forum Issue #02 Student Officer Position:

Emerging Infectious Disease Threats. Margaret A. Hamburg M.D. Foreign Secretary, U.S. National Academy of Medicine

Surveillance prioritisation and cost-effective delivery the Swedish perspective

Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared?

JOINT STATEMENT OF ASEAN PLUS THREE HEALTH MINISTERS SPECIAL MEETING ON EBOLA PREPAREDNESS AND RESPONSE Bangkok, Thailand, 15 December 2014

EC research and innovation strategy and actions

1-2 December 2015 Geneva, Switzerland. Anticipating emerging infectious disease epidemics

Strengthening regional health security: Emerging diseases and disaster preparedness and response

Global Health Security: Preparedness and Response: can we do better and stay safe?

Public Health Challenges. Identified by Public Health England

The M8 Alliance Declaration. World Health Summit 2016 (Version: 07/10/ :30)

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,

Evaluating the Economic Consequences of Avian Influenza (1) Andrew Burns, Dominique van der Mensbrugghe, Hans Timmer (2)

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

Financing international collective action for epidemic & pandemic preparedness

Global Governance for Health: Protecting Vulnerable People from Infectious Diseases in Countries with Weak Health System

Overview of the First Regional Dengue Symposium Rio de Janeiro, Brazil, 3-4 November 2015

5.4.8 Pandemic Disease

Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update

4.3.9 Pandemic Disease

ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS

Challenges and Preparedness for Emerging Zoonotic Diseases

SECTOR ASSESMENT (SUMMARY): HEALTH

2. SITUATION ANALYSIS

Progress report on emerging and re-emerging diseases including dengue and dengue haemorrhagic fever

Outline. Introduction to Epidemiology. Epidemiology. Epidemiology. History of epidemiology

Opportunities for the Future of Healthcare and Public Health Preparedness, Response, and Recovery

Geographic distribution ZIKV

APEC Ministerial Meeting on Avian and Influenza Pandemics Da Nang, Viet Nam, 4-6 May 2006

The Threat of Agroterrorism and Zoonotic Diseases in the United States

FAO s Animal Health Initiatives in Asia and the Pacific. 9th Regional Steering Committee Meeting of GF TADs for Asia and Pacific

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS

February Emerging Infectious Diseases: The Global Picture

Countries initially targeted: Bangladesh, Mongolia, Myanmar, Nepal, Lao People s Demoncratic Republic and Pakistan.

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA

Dr. Alejandro Schudel Fundación PROSAIA Argentina. 17 th IMS World Meat Congress Cape Town, South Africa, 7-10 September 2008

Future infectious disease health threats faced by the EU and the implications for laboratory capacity

Looking forward based on past experiences: What s old is new again

2/26/2018. Deadliest Enemy: Our War Against Killer Germs

FY 2017 President s Budget Request Overview for the National Center on Birth Defects and Developmental Disabilities

Copenhagen, Denmark, September August Malaria

Antimicrobial resistance Fact sheet N 194 Updated April 2014

Media centre Global infectious disease surveillance

Understanding the Economics of Microbial Threats A Workshop

TELL ME Communication Kit

Mo Salman Animal Population Health Institute, Colorado State University, Fort Collins, Colorado, , USA

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

Identifying, Preparing for & Reducing Pandemic Risk

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

European Centre for Disease Prevention and Control. Zika virus disease

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

Disease Prevention, Detection & Response During Public Health Emergencies

Chapter 2 Epidemiology. Multiple Choice Questions

Enhancing prevention and control of Rift Valley Fever in East Africa by intersectoral assessment of control options

World Health Report 2019 Predictions

DEFINING PANDEMIC. Dr Wan Noraini Wan Mohamed Noor Head of Surveillance Sector Disease Control Division, MOH Malaysia 3 May 2018

Understanding Zika Outbreak through Security Lense: A Hasty Global Health Panic

Global Catastrophic Biological Risks

1966 CDC assessment of US Health

Advanced Lecture on One Health

The Economic and Social Council, Recalling the United Nations Millennium Declaration13 and the 2005 World Summit Outcome, 1

The Current Status of the Epidemiologic Transition

YELLOW FEVER UPDATE. DPGH Meeting Dr. Grace Saguti NPO/DPC 13 July 2016

5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)

Ebola Epidemic in Coastal West Africa Overall Situation

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

Addressing climate change driven health challenges in Africa

Before and during influenza pandemics

Duane J. Gubler, ScD Professor and Founding Director, Signature Research Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore

Emerging global health threats of animal origin

E d i t o r i a l. Daniel Tarantola

EVALUATION OF HEALTH THREATS: How the EU system functions Zsuzsanna Jakab, Director of ECDC, Informal Meeting of Health Ministers

Media centre Statement on the 7th IHR Emergency Committee meeting regarding the international spread of poliovirus

The Menace of Waves of Infectious Diseases

IS THE UK WELL PREPARED FOR A REPEAT OF THE 1918 INFLUENZA PANDEMIC?

High Level Summary and Recommendations

DRAFT CCH III. Reduction of new infections and morbidity and mortality due to communicable diseases

Emerging Infectious Disease Categories (NIAID) 1 of 3

PARALLEL SESSION 2.4

Introduction to Public Health and Epidemiology

Pandemic Influenza Preparedness

Fact sheet. Yellow fever

MINISTERIAL CONFERENCE ON MALARIA

EPI 220: Principles of Infectious Disease Epidemiology UCLA School of Public Health Syllabus Winter 2016

Public Health Resources: Core Capacities to Address the Threat of Communicable Diseases

Surveillance Protocol Dengue Fever (Breakbone fever, Dengue Hemorrhagic Fever)

Collaborations in more than 50 countries. 400 scientific papers published every year. Over 800 professionals trained every year

ZIKA AND MOSQUITO- BORNE ILLNESSES

The Islamic University of Gaza- Civil and Environmental Engineering Department Public Health (EENV-5325)

H1N1: an International Perspective. Jean Luc Poncelet, MD, MPH PAHO/WO Emergency Preparedness and disaster relief

Pandemic Influenza: U.S. Government Perspective on International Issues

DISEASE OUTBREAK

GloPID-R. Objectives, governance, activities, priorities. Joint meeting. DG Research & Innovation - Acting Director Health

Mosquito-borne virus prevention and control: a global perspective

IFMSA Policy Proposal [Control of Emerging Infectious Diseases]

MIGRATION, HUMAN MOBILITY & HIV ACCESS TO PREVENTION AND CARE

Transcription:

Assessing economic vulnerability to emerging infectious disease outbreaks: Ebola versus Zika Dr Anas El Turabi National Academy of Medicine Forum on Antimicrobial Threats June 12, 2018

The ultimate goal of economic analysis (?) Question Prediction Resource allocation decision

The 2 methods of economic analysis

Simplified model of infectious disease economic impacts Transmission dynamics model Reservoir Other vectors Primary vector Humans Social responses Biological responses Individuals Government Illness C S C P Organisations Death P s Recovery C I E R Disability C L P L P L C S P E C L P L Economic impact model Disease dynamic model

Simplified model of infectious disease economic impacts Transmission dynamics model Reservoir Other vectors Primary vector Humans Social responses Biological responses Individuals Government Illness C S C P Organisations Death P s Recovery C I E R Disability C L P L P L C S P E C L P L Economic impact model Disease dynamic model

Economic vulnerability to outbreaks is an intersectoral issue Intrinsic vulnerability Pandemic preparedness and response Industry sector vulnerability Overall assessment

Comparing Ebola and Zika

Ebola and Zika disease dynamics Ebola Zika PHEIC dates Aug 2014 - Mar 2016 Feb 2016 - Nov 2016 Months PHEIC active 20 10 WHO regions affected during PHEIC period Countries reporting during PHEIC period 3 Estimated cases during PHEIC period 1 4 60 (+18 with active transmission pre-2015) 28,639 518,000 Deaths attributed 11,316 15 Indirect deaths from healthcare diversion ~10,000 additional malaria deaths None estimated Status at end of PHEIC Quiescent Active

Ebola and Zika disease dynamics Ebola 1 Zika 2 PHEIC dates Aug 2014 - Mar 2016 Feb 2016 - Nov 2016 Months PHEIC active 20 10 WHO regions affected during PHEIC period Countries reporting during PHEIC period 3 Estimated cases during PHEIC period 1 4 60 (+18 with active transmission pre-2015) 28,639 518,000 Deaths attributed 11,316 15 Indirect deaths from healthcare diversion ~10,000 additional malaria deaths None estimated Status at end of PHEIC Quiescent Active

Ebola and Zika economic impacts Ebola 1 Zika 2 Short term costs (3yr) ~ $3 billion ~ $7-18 billion Long term costs Not calculated $11 billion lifetime care microcephaly Principal sectors affected Agriculture Mining Informal Trade, tourism & mobility Agriculture Trade, tourism & mobility Informal 1. 2014-2015 West Africa Ebola Crisis: Impact Update. World Bank (May 2016). 2. A Socio-economic Impact Assessment of the Zika Virus in Latin America and the Caribbean: with a focus on Brazil, Colombia and Suriname. UNDP (April 2017).

Conclusions and recommendations Economic impacts decoupling from direct health impacts Economic impacts outlast epidemiological events Post hoc analysis we are doing better but local capacity constraints remain Need to address model dependence

The 2 methods of economic analysis

Better understanding of sectoral sensitivity can help inform economic models of impact Feb 1: WHO declares PHEIC S&P 500 Carnival Corporation Carnival UK Royal Caribbean Cruises Ltd

Short run GDP effects of Ebola were substantial

The 2 questions of economic analysis How bad will it be? How bad was it? Causal inference

Vulnerability The susceptibility of an economic system to disruption by a specified hazard. Implies causal relationship between threat/system interaction and outcome (disruption). Two components: Likelihood: risk of threat occurring Impact: likely effect conditional on occurrence

Assessing economic vulnerability to infectious disease crises requires assessment across multiple domains Intrinsic vulnerability Risk of disease emergence Social and behavioral impact modifiers Healthcare system strength Pandemic preparedness and response Capability across JEE domains: Prevention Detection Response Industry sector vulnerability Sectoral composition of economy Sectoral sensitivity to outrbeaks Trade and labor dependencies Overall assessment Overall assessment of economic vulnerability and policy effectiveness to incorporate into broader economic analysis

Economic analysis is No omnibus goal Advocacy vs. learning Normative vs. positive No single best tool No ground truth(?) At best, one input into decision making processes

Drivers of outbreak risk are multisectoral Eradication Endemic Disease Risk Pool Increased rate of new EIDs Intensive agricultural practices Animal-human densification Climate and ecological change Emerging Infectious Disease Outbreak Epidemic Pandemic Increased susceptibility of immunocompromised populations (HIV/AIDS, malnutrition) Inadequate country-level surveillance and control systems Global trends in migration, trade & transport Failures of global health coordination Inadequate resources for pandemic responsiveness by IGOs Limited ability to detect outbreaks early Underinvestment in R&D for EID diagnostic and vaccine platforms Antimicrobial resistance